Skip to main content

Table 2 Upper range of vaccination costs per individual (US dollar) for a Zika vaccine candidate to be cost-saving (ICER < 0), highly cost-effective (WTP of per capita GDP) or cost-effective (WTP of three times per capita GDP)

From: Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia

 

0% herd immunity

8% herd immunity

RTA

10%

90%

10%

90%

  

WTP

 

WTP

 

WTP

 

WTP

R 0

ICER < 0

$6610

$19,832

ICER < 0

$6610

$19,832

ICER < 0

$6610

$19,832

ICER < 0

$6610

$19,832

2.2

$6

$10

$16

$12

$16

$29

$4

$7

$13

$6

$8

$14

2.8

$29

$38

$53

$35

$45

$66

$16

$22

$35

$20

$27

$45

  1. ICER incremental cost-effectiveness ratio, RTA relative transmissibility of asymptomatic infection, WTP willingness-to-pay